Florian brings over 20 years of experience in financial leadership roles within the biopharmaceutical, technology and consulting sectors. Prior to joining T-CURX, he served as CFO of iOmx, a clinical-stage biopharmaceutical company developing biomarker-enabled oncology programs. 

Previously, he worked as CFO at Vivoryon Therapeutics, and as Director of Finance at InflaRx and held various management positions at Deutsche Telekom. At both InflaRx and Vivoryon, he participated in various corporate finance transactions, including a Nasdaq IPO and follow-on financing rounds. 

Florian earned a degree in business economics from the Ludwig-Maximilians University of Munich and started his professional career at Arthur Andersen and Ernst & Young. He is a Certified Public Accountant and Certified German Tax Advisor.